T. Rowe Price Group, Inc.
T. Rowe Price Group, Inc. (TR1.DU) Financial Performance & Income Statement Overview
Review T. Rowe Price Group, Inc. (TR1.DU) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
T. Rowe Price Group, Inc. (TR1.DU) Income Statement & Financial Overview
Explore comprehensive income reports for T. Rowe Price Group, Inc. TR1.DU, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.76B | $1.82B | $1.79B | $1.73B |
Cost of Revenue | $841.90M | $875.00M | $844.90M | $821.80M |
Gross Profit | $922.00M | $949.50M | $940.70M | $911.50M |
Gross Profit Ratio | $0.52 | $0.52 | $0.53 | $0.53 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $297.00M | $321.70M | $289.00M | $302.90M |
Operating Expenses | $325.70M | $1.26B | $327.10M | $346.80M |
Total Costs & Expenses | $1.17B | $1.26B | $1.17B | $1.17B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $315.80M | $134.50M | $187.80M |
EBITDA | $688.60M | $568.40M | $651.70M | $796.40M |
EBITDA Ratio | $0.39 | $0.31 | $0.36 | $0.46 |
Operating Income | $596.30M | $568.40M | $613.60M | $564.70M |
Operating Income Ratio | $0.34 | $0.31 | $0.34 | $0.33 |
Other Income/Expenses (Net) | $70.70M | $4.60M | $212.50M | $80.30M |
Income Before Tax | $667.00M | $573.00M | $826.10M | $645.00M |
Income Before Tax Ratio | $0.38 | $0.31 | $0.46 | $0.37 |
Income Tax Expense | $161.90M | $156.30M | $185.70M | $159.70M |
Net Income | $490.50M | $428.30M | $603.00M | $483.40M |
Net Income Ratio | $0.28 | $0.23 | $0.34 | $0.28 |
EPS | $2.15 | $2.18 | $2.64 | $2.11 |
Diluted EPS | $2.15 | $2.18 | $2.64 | $2.11 |
Weighted Avg Shares Outstanding | $223.30M | $222.80M | $222.30M | $223.00M |
Weighted Avg Shares Outstanding (Diluted) | $223.30M | $222.80M | $222.80M | $223.50M |
The company's financials show resilient growth, with revenue advancing from $1.73B in Q2 2024 to $1.76B in Q1 2025. Gross profit remained healthy with margins at 52% in Q1 2025 compared to 53% in Q2 2024. Operating income hit $596.30M last quarter, sustaining a consistent 34% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $688.60M. Net income rose to $490.50M, while earnings per share reached $2.15. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan